Curaxin CBL0100 Blocks HIV-1 Replication and Reactivation through Inhibition of Viral Transcriptional Elongation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Curaxin CBL0100 Blocks HIV-1 Replication and Reactivation through Inhibition of Viral Transcriptional Elongation
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-10-17
DOI
10.3389/fmicb.2017.02007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HIV Latency: Should We Shock or Lock?
- (2017) Gilles Darcis et al. TRENDS IN IMMUNOLOGY
- A Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association
- (2017) Huachao Huang et al. Frontiers in Microbiology
- The mTOR Complex Controls HIV Latency
- (2016) Emilie Besnard et al. Cell Host & Microbe
- The Structure-Specific Recognition Protein 1 Associates with Lens Epithelium-Derived Growth Factor Proteins and Modulates HIV-1 Replication
- (2016) Angelica P. Lopez et al. JOURNAL OF MOLECULAR BIOLOGY
- Inhibition of the FACT Complex Reduces Transcription from the Human Cytomegalovirus Major Immediate Early Promoter in Models of Lytic and Latent Replication
- (2016) Christine M. O'Connor et al. JOURNAL OF VIROLOGY
- Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size
- (2016) Nathan W. Cummins et al. JOURNAL OF VIROLOGY
- The Effect of Latency Reversal Agents on Primary CD8 + T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication
- (2016) Victoria E. Walker-Sperling et al. EBioMedicine
- Inhibition of HIV-1 reactivation by a telomerase-derived peptide in a HSP90-dependent manner
- (2016) Hong Kim et al. Scientific Reports
- FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency
- (2015) Huachao Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ex vivo analysis identifies effective HIV-1 latency–reversing drug combinations
- (2015) Gregory M. Laird et al. JOURNAL OF CLINICAL INVESTIGATION
- IFI44 suppresses HIV-1 LTR promoter activity and facilitates its latency
- (2015) Derek Power et al. VIROLOGY
- The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency
- (2015) Guillaume Mousseau et al. mBio
- An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression
- (2015) Gilles Darcis et al. PLoS Pathogens
- New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
- (2014) C Korin Bullen et al. NATURE MEDICINE
- Eradicating HIV-1 infection: seeking to clear a persistent pathogen
- (2014) Nancie M. Archin et al. NATURE REVIEWS MICROBIOLOGY
- HIV-1 Latency in Monocytes/Macrophages
- (2014) Amit Kumar et al. Viruses-Basel
- Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
- (2013) Ya-Chi Ho et al. CELL
- An Integrated Overview of HIV-1 Latency
- (2013) Debbie S. Ruelas et al. CELL
- Altering cell death pathways as an approach to cure HIV infection
- (2013) A D Badley et al. Cell Death & Disease
- An Analog of the Natural Steroidal Alkaloid Cortistatin A Potently Suppresses Tat-Dependent HIV Transcription
- (2012) Guillaume Mousseau et al. Cell Host & Microbe
- Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
- (2012) Liang Shan et al. IMMUNITY
- Reactivation of Latent HIV-1 by Inhibition of BRD4
- (2012) Jian Zhu et al. Cell Reports
- The Control of HIV Transcription: Keeping RNA Polymerase II on Track
- (2011) Melanie Ott et al. Cell Host & Microbe
- Generation of HIV Latency in Humanized BLT Mice
- (2011) P. W. Denton et al. JOURNAL OF VIROLOGY
- Curaxins: Anticancer Compounds That Simultaneously Suppress NF- B and Activate p53 by Targeting FACT
- (2011) A. V. Gasparian et al. Science Translational Medicine
- HIV reservoirs and latency models
- (2011) Matthew J. Pace et al. VIROLOGY
- Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
- (2010) Steven A Yukl et al. AIDS
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
- (2009) Nicolas Chomont et al. NATURE MEDICINE
- Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells
- (2008) A. Bosque et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now